BrightSpring Health Services, Inc. (BTSG) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BTSG SEC filings page.
BrightSpring Health Services, Inc. (BTSG) reported $14.4B in revenue over the twelve months to Jun 30, 2026, up 33.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue scale is improving cash generation and operating leverage, even as gross-margin economics continue to compress.
From FY2024 to FY2025, operating margin more than doubled to2.3% , while gross margin declined over the same period. That split indicates cost absorption below gross profit, rather than improved direct service economics, drove the profitability step-up; revenue expansion was not accompanied by a stronger gross-profit engine.
FY2025 net income of
The capital structure also changed materially: debt-to-equity fell from 5.7x in FY2023 to 1.3x in FY2025, showing lower leverage relative to shareholder capital and a changed financing mix. Current ratio rose from 1.2x to 1.6x, suggesting short-term obligations became easier to fund from current assets, while the business still relies materially on liabilities to finance its asset base.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of BrightSpring Health Services, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
BrightSpring Health Services, Inc. has an operating margin of 2.3%, meaning the company retains $2 of operating profit per $100 of revenue. This results in a moderate score of 45/100, indicating healthy but not exceptional operating efficiency. This is up from 1.1% the prior year.
BrightSpring Health Services, Inc.'s revenue surged 28.2% year-over-year to $12.9B, reflecting rapid business expansion. This strong growth earns a score of 89/100.
BrightSpring Health Services, Inc. has elevated debt relative to equity (D/E of 1.31), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 11/100, reflecting increased financial risk.
BrightSpring Health Services, Inc.'s current ratio of 1.57 indicates adequate short-term liquidity, earning a score of 44/100. The company can meet its near-term obligations, though with limited headroom.
BrightSpring Health Services, Inc. has a free cash flow margin of 3.1%, earning a moderate score of 31/100. The company generates positive cash flow after capital investments, but with room for improvement.
BrightSpring Health Services, Inc.'s ROE of 10.1% shows moderate profitability relative to equity, earning a score of 46/100. This is up from 1.3% the prior year.
BrightSpring Health Services, Inc. scores 3.97, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
BrightSpring Health Services, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, BrightSpring Health Services, Inc. generates $2.59 in operating cash flow ($490.2M OCF vs $189.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
BrightSpring Health Services, Inc. earns $1.88 in operating income for every $1 of interest expense ($295.3M vs $157.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
BrightSpring Health Services, Inc. generated $3.9B in revenue in Q2 2026. This represents an increase of 23.0% from the same quarter a year earlier. Against the prior quarter it is up 7.2%.
BrightSpring Health Services, Inc.'s EBITDA was $171.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 90.1% from the same quarter a year earlier. Against the prior quarter it is up 7.0%.
BrightSpring Health Services, Inc. reported $84.3M in net income in Q2 2026. This represents an increase of 198.8% from the same quarter a year earlier. Against the prior quarter it is down 43.3%.
BrightSpring Health Services, Inc. earned $0.38 per diluted share (EPS) in Q2 2026. This represents an increase of 192.3% from the same quarter a year earlier. Against the prior quarter it is down 43.3%.
Cash & Balance Sheet
BrightSpring Health Services, Inc. generated $14.9M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 39.6% from the same quarter a year earlier. Against the prior quarter it is down 85.3%.
BrightSpring Health Services, Inc. held $550.4M in cash against $2.1B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
BrightSpring Health Services, Inc.'s gross margin was 12.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.6 percentage points.
BrightSpring Health Services, Inc.'s operating margin was 3.4% in Q2 2026, reflecting core business profitability. This is up 1.8 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.
BrightSpring Health Services, Inc.'s net profit margin was 2.2% in Q2 2026, showing the share of revenue converted to profit. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.9 percentage points.
BrightSpring Health Services, Inc.'s ROE was 4.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.4 percentage points.
Capital Allocation
BrightSpring Health Services, Inc. spent $60.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. It is unchanged from the prior quarter.
BrightSpring Health Services, Inc. invested $29.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 18.9% from the same quarter a year earlier. Against the prior quarter it is up 34.8%.
Not reported for Q2 2026.
BTSG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9B+23.0% | $3.6B+25.6% | $3.6B+91.0% | $3.3B+14.7% | $3.1B+15.3% | $2.9B+11.7% | $1.9B+50.0% | $2.9B+28.8% |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $2.5B+31.6% |
| Gross Profit | $492.7M+31.5% | $482.2M+42.5% | $412.5M+21.8% | $392.0M+21.3% | $374.9M+20.1% | $338.4M+15.7% | $338.7M+358.2% | $323.1M-9.8% |
| SG&A Expenses | $362.4M+11.1% | $360.8M+25.4% | $304.4M+7.5% | $304.2M+3.5% | $326.3M+19.3% | $287.6M-6.6% | $283.1M+198.9% | $294.0M-28.4% |
| Operating Income | $130.4M+168.5% | $121.4M+139.4% | $108.1M+94.7% | $87.8M+201.9% | $48.6M+25.6% | $50.7M+430.9% | $55.5M+367.1% | $29.1M+155.7% |
| EBITDA | $171.8M+90.1% | $160.5M+72.8% | $147.6M+33.7% | $128.6M+61.3% | $90.4M+1.9% | $92.9M+176.6% | $110.4M+265.4% | $79.7M+5489.1% |
| Interest Expense | $36.9M-4.9% | $38.6M-7.5% | $38.5M-16.6% | $38.2M-18.0% | $38.8M-10.4% | $41.8M-23.3% | $46.2M+52.1% | $46.6M-44.3% |
| Income Tax | $6.9M+458.0% | $8.6M+3662.9% | $20.0M+294.5% | $12.1M+48.6% | $1.2M+109.4% | -$240K+99.1% | $5.1M+127.4% | $8.2M+240.4% |
| Net Income | $84.3M+198.8% | $148.8M+403.6% | $75.5M+38.4% | $55.8M+778.4% | $28.2M+41.6% | $29.5M+164.6% | $54.6M+935.0% | -$8.2M+93.7% |
| EPS (Basic) | $0.41+192.9% | $0.73+386.7% | $0.38+322.2% | $0.27+775.0% | $0.14+40.0% | $0.15+157.7% | $0.09+280.0% | -$0.04+96.4% |
| EPS (Diluted) | $0.38+192.3% | $0.67+378.6% | $0.35 | $0.26+750.0% | $0.13+30.0% | $0.14+153.8% | $0.09 | -$0.04 |
| Diluted Shares (Avg) | 220M+1.8% | 221M+3.0% | N/A | 218M+9.8% | 216M+3.5% | 215M+22.4% | N/A | 198M |
Not reported in any period shown, so not listed: R&D Expenses.
BTSG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.0B+0.7% | $6.2B+6.3% | $6.4B+8.2% | $6.0B+4.6% | $5.9B+6.0% | $5.8B+3.4% | $5.9B+7.1% | $5.8B |
| Current Assets | $2.5B-6.7% | $2.7B+6.4% | $2.9B+52.9% | $2.8B+62.6% | $2.6B+74.0% | $2.5B+60.8% | $1.9B+30.0% | $1.7B |
| Cash & Equivalents | $550.4M+685.5% | $888.8M+1598.2% | $88.4M+45.0% | $140.3M+290.1% | $70.1M+180.0% | $52.3M-9.8% | $61.0M+390.4% | $36.0M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $575.0M-8.1% | $560.2M+5.0% | $815.2M+28.1% | $639.2M+33.6% | $625.5M+67.1% | $533.6M+42.8% | $636.6M+59.6% | $478.3M |
| Accounts Receivable | $1.1B+17.1% | $1.1B+14.2% | $989.7M+9.6% | $1.0B-1.2% | $972.7M-1.2% | $975.3M-1.5% | $902.8M+17.7% | $1.0B |
| Long-Term Investments | $7.5M | $7.5M | $7.5M+424.2% | $0 | $0 | $0 | $1.4M | $0 |
| Goodwill | $2.5B+7.0% | $2.5B+6.9% | $2.5B+7.7% | $2.4B-11.3% | $2.4B-9.8% | $2.4B-9.2% | $2.4B+2.7% | $2.7B |
| Total Liabilities | $3.9B-6.4% | $4.2B+1.6% | $4.5B+5.9% | $4.2B+1.5% | $4.2B+5.0% | $4.2B+1.8% | $4.3B-13.1% | $4.2B |
| Current Liabilities | $1.6B+3.3% | $1.5B+6.2% | $1.8B+29.5% | $1.5B+22.6% | $1.5B+31.5% | $1.5B+17.1% | $1.4B+14.4% | $1.3B |
| Non-Current Liabilities | $2.4B-11.9% | $2.7B-0.9% | $2.7B-5.9% | $2.7B-7.7% | $2.7B-5.7% | $2.7B-4.8% | $2.8B-22.5% | $2.9B |
| Long-Term Debt | $2.1B-13.3% | $2.4B-1.8% | $2.5B-4.2% | $2.5B-5.5% | $2.5B-3.3% | $2.5B-1.0% | $2.6B-23.1% | $2.6B |
| Total Equity | $2.0B+17.5% | $2.0B+17.3% | $1.9B+13.8% | $1.8B+12.6% | $1.7B+9.0% | $1.7B+7.6% | $1.6B+181.8% | $1.6B+155.7% |
| Retained Earnings | $38.4M+123.4% | $14.1M+107.3% | -$74.6M+66.4% | -$108.6M+53.7% | -$164.4M+27.3% | -$192.6M+21.7% | -$222.2M-10.9% | -$234.4M |
BTSG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $43.9M-10.5% | $122.9M+21.0% | $231.6M+155.6% | $107.9M+296.2% | $49.1M+422.3% | $101.6M+228.8% | $90.6M-44.2% | $27.2M-19.1% |
| Depreciation & Amortization | $41.4M-1.0% | $39.1M-7.3% | $39.5M-28.0% | $40.8M-19.5% | $41.8M-16.4% | $42.2M-13.8% | $54.9M+7.6% | $50.6M-0.3% |
| Stock-Based Compensation | N/A | $3.7M-76.6% | N/A | N/A | N/A | $15.7M-36.9% | N/A | N/A |
| Capital Expenditures | $29.0M+18.9% | $21.5M+22.2% | $37.7M+146.0% | $15.8M-21.4% | $24.4M+2.9% | $17.6M-19.2% | $15.3M-9.0% | $20.0M+12.0% |
| Free Cash Flow | $14.9M-39.6% | $101.4M+20.8% | $193.9M+157.5% | $92.2M+1179.7% | $24.7M+163.3% | $84.0M+183.4% | $75.3M-48.3% | $7.2M-54.4% |
| Investing Cash Flow | -$28.2M-21.3% | $747.4M+3189.5% | -$233.9M-1382.2% | -$23.8M+33.7% | -$23.2M+59.7% | -$24.2M+21.8% | -$15.8M+7.3% | -$35.8M+34.4% |
| Financing Cash Flow | -$354.1M-4196.2% | -$70.0M+18.6% | -$50.5M-1.9% | -$13.1M-167.1% | -$8.2M-120.7% | -$86.0M-155.6% | -$49.6M+65.6% | $19.5M-8.5% |
| Share Buybacks | $60.0M | $60.0M | N/A | N/A | N/A | N/A | $0-100.0% | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
BTSG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.7%+0.8pp | 13.3%+1.6pp | 11.6%-6.6pp | 11.8%+0.6pp | 11.9%+0.5pp | 11.8%+0.4pp | 18.2%+12.3pp | 11.1%-4.8pp |
| Operating Margin | 3.4%+1.8pp | 3.4%+1.6pp | 3.0%+0.1pp | 2.6%+1.6pp | 1.5%+0.1pp | 1.8%+2.4pp | 3.0%+4.7pp | 1.0%+3.3pp |
| Net Margin | 2.2%+1.3pp | 4.1%+3.1pp | 2.1%-0.8pp | 1.7%+1.9pp | 0.9%+0.2pp | 1.0%+2.8pp | 2.9%+3.5pp | -0.3%+5.5pp |
| Return on Equity | 4.1%+2.5pp | 7.5%+5.8pp | 4.0%+0.7pp | 3.1%+3.6pp | 1.6%+0.4pp | 1.8%+4.7pp | 3.3%+4.4pp | -0.5%+20.2pp |
| Return on Assets | 1.4%+0.9pp | 2.4%+1.9pp | 1.2%+0.3pp | 0.9%+1.1pp | 0.5%+0.1pp | 0.5%+1.3pp | 0.9%+1.0pp | -0.1% |
| Current Ratio | 1.59-0.2x | 1.740.0x | 1.57+0.2x | 1.79+0.4x | 1.76+0.4x | 1.73+0.5x | 1.33+0.2x | 1.35 |
| Debt-to-Equity | 1.05-0.4x | 1.24-0.2x | 1.31-0.2x | 1.36-0.3x | 1.42-0.2x | 1.48-0.1x | 1.55-4.1x | 1.62 |
| Asset Turnover | 0.65+0.1x | 0.58+0.1x | 0.55+0.2x | 0.550.0x | 0.530.0x | 0.490.0x | 0.31+0.1x | 0.50 |
| FCF Margin | 0.4%-0.4pp | 2.8%-0.1pp | 5.5%+1.4pp | 2.8%+2.5pp | 0.8%+2.2pp | 2.9%+6.8pp | 4.0%-7.7pp | 0.3%-0.5pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| BrightSpring Health Services, Inc. BTSG | FY2025 | $12.9B | $189.1M | 1.5% | $12.3B | 44/100 |
| Waystar Holding Corp. WAY | FY2025 | $1.1B | $112.1M | 10.2% | $4.6B | 59/100 |
| Healthequity Inc HQY | FY2026 | $1.3B | $215.2M | 16.4% | $7.7B | 68/100 |
| Privia Health Group, Inc. PRVA | FY2025 | $2.1B | $22.9M | 1.1% | $2.7B | 47/100 |
| Omnicell Com OMCL | FY2025 | $1.2B | $2.1M | 0.2% | $1.5B | 42/100 |
Where BrightSpring Health Services, Inc. Ranks
Frequently Asked Questions
What is BrightSpring Health Services, Inc.'s annual revenue?
BrightSpring Health Services, Inc. (BTSG) reported $12.9B in total revenue for fiscal year 2025. This represents a 28.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is BrightSpring Health Services, Inc.'s revenue growing?
BrightSpring Health Services, Inc. (BTSG) revenue grew by 28.2% year-over-year, from $10.1B to $12.9B in fiscal year 2025.
Is BrightSpring Health Services, Inc. profitable?
Yes, BrightSpring Health Services, Inc. (BTSG) reported a net income of $189.1M in fiscal year 2025, with a net profit margin of 1.5%.
What is BrightSpring Health Services, Inc.'s EBITDA?
BrightSpring Health Services, Inc. (BTSG) had EBITDA of $459.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does BrightSpring Health Services, Inc. have?
As of fiscal year 2025, BrightSpring Health Services, Inc. (BTSG) had $88.4M in cash and equivalents against $2.5B in long-term debt.
What is BrightSpring Health Services, Inc.'s gross margin?
BrightSpring Health Services, Inc. (BTSG) had a gross margin of 11.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is BrightSpring Health Services, Inc.'s operating margin?
BrightSpring Health Services, Inc. (BTSG) had an operating margin of 2.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is BrightSpring Health Services, Inc.'s net profit margin?
BrightSpring Health Services, Inc. (BTSG) had a net profit margin of 1.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is BrightSpring Health Services, Inc.'s return on equity (ROE)?
BrightSpring Health Services, Inc. (BTSG) has a return on equity of 10.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is BrightSpring Health Services, Inc.'s free cash flow?
BrightSpring Health Services, Inc. (BTSG) generated $394.7M in free cash flow during fiscal year 2025. This represents a 790.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is BrightSpring Health Services, Inc.'s operating cash flow?
BrightSpring Health Services, Inc. (BTSG) generated $490.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are BrightSpring Health Services, Inc.'s total assets?
BrightSpring Health Services, Inc. (BTSG) had $6.4B in total assets as of fiscal year 2025, including both current and long-term assets.
What are BrightSpring Health Services, Inc.'s capital expenditures?
BrightSpring Health Services, Inc. (BTSG) invested $95.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is BrightSpring Health Services, Inc.'s current ratio?
BrightSpring Health Services, Inc. (BTSG) had a current ratio of 1.57 as of fiscal year 2025, which is generally considered healthy.
What is BrightSpring Health Services, Inc.'s debt-to-equity ratio?
BrightSpring Health Services, Inc. (BTSG) had a debt-to-equity ratio of 1.31 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is BrightSpring Health Services, Inc.'s return on assets (ROA)?
BrightSpring Health Services, Inc. (BTSG) had a return on assets of 2.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is BrightSpring Health Services, Inc.'s P/E ratio?
BrightSpring Health Services, Inc. (BTSG) trades at 33.7x earnings, its market capitalization divided by net income of $364.4M net income, trailing 12 months to June 30, 2026. The market capitalization is $12.3B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is BrightSpring Health Services, Inc.'s price-to-sales ratio?
BrightSpring Health Services, Inc. (BTSG) trades at 0.9x sales, its market capitalization divided by revenue of $14.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $12.3B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is BrightSpring Health Services, Inc.'s Altman Z-Score?
BrightSpring Health Services, Inc. (BTSG) has an Altman Z-Score of 3.97, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is BrightSpring Health Services, Inc.'s Piotroski F-Score?
BrightSpring Health Services, Inc. (BTSG) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are BrightSpring Health Services, Inc.'s earnings high quality?
BrightSpring Health Services, Inc. (BTSG) has an earnings quality ratio of 2.59x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can BrightSpring Health Services, Inc. cover its interest payments?
BrightSpring Health Services, Inc. (BTSG) has an interest coverage ratio of 1.88x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is BrightSpring Health Services, Inc.?
BrightSpring Health Services, Inc. (BTSG) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.